Evidence shows Coffee drinkers have a lower risk of liver diseases

Health & LifestyleNews
262

Listen to article (english)

Translate to Spanish or other 102 languages!

Regular coffee drinkers have better liver health, a new review finds. Image for illustration purposes
Regular coffee drinkers have better liver health, a new review finds. Image for illustration purposes

Mega Doctor News

- Advertisement -

MEDICAL NEWS TODAY

An expansive new review published in Biochemical Pharmacology. adds to existing evidence that drinking coffee regularly can help protect and even restore the health of one’s liver by inhibiting scarring and inflammation.

In addition to affirming previously noted associations between coffee and liver health, the review identifies potential molecular pathways that explain these beneficial relationships.

- Advertisement -

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/coffee-lower-risk-liver-diseases?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-09-29&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
STHS Heart is the First RGV Facility to Successfully Implant Innovative, Heart Failure Treatment Device
Next article
Ready-To-Eat Meals Containing Pasta May Be Contaminated with Listeria

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.
- Advertisement -